Join

Press Releases

Delayed 3m

Fastest customizable press release feed in the world.

Signed out · 3-min delay · Sign up for real-time

  • Tanger Inc. logo
    PR··Real Estate·
    Tanger Recognized by Newsweek for Workplace Culture and by Nareit for Investor Communications Excellence

    Company earns national recognition for employee culture, inclusion, and investor communications leadership Tanger® (NYSE:SKT), a leading owner and operator of outlet and other open-air retail shopping destinations, has been recognized with two national awards highlighting its commitment to workplace culture and investor communications excellence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612684684/en/Tanger has been recognized as one of "America's Greatest Midsized Workplaces" 2026 by Newsweek and market-data research firm Plant-A Insights Group. "We believe strong culture and clear communication go hand in hand," said

  • Cogent Biosciences Inc. logo
    PR··Health Care·
    Cogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematology Association (EHA) Congress

    - JAK2 V671F poster presentation showcases potential best-in-class properties, including improved selectivity compared with currently approved JAK inhibitors - - Selective JAK V617F inhibitor, CGT1145, on track for IND in 2026 - WALTHAM, Mass. and BOULDER, Colo., June 12, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (NASDAQ:COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced preclinical data from its novel, potential best-in-class JAK2 V617F mutant-selective inhibitor in a poster presentation at the 2026 European Hematology Association (EHA) Congress taking place in Stockholm, Sweden, June 11-14, 2026. "We'r

  • Triple Flag Precious Metals Corp. logo
    PR··Industrials·
    Triple Flag Announces US$440 Million Gold Stream on the Ravenswood Gold Mine and Increases 2030 Outlook

    Triple Flag Precious Metals Corp. (with its subsidiaries, "Triple Flag" or the "Company") (TSX:TFPM, NYSE:TFPM) announces that its wholly owned subsidiary, Triple Flag International Ltd., has entered into an agreement to acquire a gold stream (the "Stream") on the producing Ravenswood Gold Mine in Queensland, Australia for upfront cash consideration of US$440 million. Unless otherwise indicated, all amounts are expressed in US dollars. "Triple Flag is very pleased to enter into an agreement to acquire a gold stream on the Ravenswood open-pit gold mine in Australia," commented Sheldon Vanderkooy, CEO. "The Ravenswood stream adds immediate cash flow from a large-scale, long-life operation l

  • Silvercorp Metals Inc. logo
    PR··Basic Materials·
    Silvercorp reports a Mineral Reserve increase of 50% in tonnes and 20% in silver ounces for the Ying Mining District

    Trading Symbol: TSX/NYSE American: SVMVANCOUVER, BC, June 12, 2026 /CNW/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX:SVM) (NYSE:SVM) is pleased to report the results of an updated Technical Report ("Ying 2026 Technical Report" or "Technical Report") titled "NI 43-101 Technical Report Update on the Ying Ag-Pb-Zn-Au Property in Henan Province, People's Republic of China", prepared in accordance with National Instrument 43‑101 Standards of Disclosure for Mineral Projects ("NI 43-101") by AMC Mining Consultants (Canada) Ltd. ("AMC") with a Mineral Reserve and Mineral Resource effective date of December 31, 2025. The Ying 2026 Technical Report covers seven underground mines (nam

  • Jazz Pharmaceuticals plc logo
    PR··Health Care·
    Jazz Pharmaceuticals Provides Update on Zepzelca® (lurbinectedin) Phase 3 LAGOON Trial in Second-Line Small Cell Lung Cancer

    For U.S. media and investors onlyDUBLIN, June 12, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced top-line results from the Phase 3 LAGOON trial, conducted by PharmaMar, evaluating Zepzelca® (lurbinectedin) in patients with relapsed (second-line) metastatic small cell lung cancer (SCLC). The trial did not meet its primary endpoint of overall survival (OS) evaluating Zepzelca as monotherapy or in combination with irinotecan compared to investigators' choice of topotecan or irinotecan. No new safety signals were identified with Zepzelca monotherapy or in combination with irinotecan, and the overall safety profiles of the investigational arms were consistent with the

  • OPENLANE Inc. logo
    PR··Consumer Discretionary·
    OPENLANE Appoints Kelly Tuminelli and David Hult to Board of Directors

    New Directors Bring Deep Automotive Retail, Public Company Leadership and Financial ExpertiseCARMEL, Ind., June 12, 2026 /PRNewswire/ -- OPENLANE, Inc. (NYSE:OPLN), a leading operator of digital marketplaces for wholesale used vehicles, announces the appointment of Kelly Tuminelli and David Hult to its Board of Directors. Together, Tuminelli and Hult bring extensive public company leadership experience, deep operational and financial expertise, and complementary records of driving growth and value for both customers and stockholders. "We are delighted to welcome Kelly and David to our Board and look forward to drawing on their

  • Pixelworks Inc. logo
    PR··Technology·
    Pixelworks and CINITY Partner to Expand TrueCut Motion Ecosystem

    Collaboration to Bring Increased Motion-Enhanced Content to Ultra-Premium Large Format Cinematic Experiences GloballyLOS ANGELES, June 12, 2026 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ:PXLW) ("Pixelworks" or the "Company"), a provider of innovative cinematic and enhanced visualization solutions, today announced a partnership with China Film CINITY Co., Ltd. ("CINITY") to bring advanced TrueCut Motion grading technology to CINITY's premium large format theaters. Together with its endorsement of TrueCut Motion technology, CINITY is prioritizing the screening of TrueCut Motion-enhanced versions of tent pole movies across its premium large format auditoriums in order to give audiences the most v

  • Carnival Corporation logo
    PR··Consumer Discretionary·
    Cunard Invites Travelers to Win an Experience On Queen Mary 2's Historic 450th Transatlantic Crossing

    As Cunard celebrates America's 250th anniversary, travelers can enter for a chance to sail aboard the world's only ocean liner for an incredible milestone crossingVALENCIA, Calif., June 12, 2026 /CNW/ -- As Queen Mary 2 prepares to join Sail4th 250 this July – celebrating America's 250th anniversary in New York Harbor – Cunard is inviting travelers to become part of its next historic milestone at sea. The British luxury cruise brand has launched a sweepstakes* to celebrate Queen Mary 2's historic 450th Transatlantic Crossing this November – a voyage that continues Cunard's enduring legacy of connecting the United Kingdom and the United States through ocean travel.

  • Braemar Hotels & Resorts Inc. logo
    PR··Real Estate·
    BRAEMAR HOTELS & RESORTS ANNOUNCES CONCLUSION OF STRATEGIC REVIEW PROCESS AND PLAN TO BECOME A SELF-MANAGED REIT AND REMAIN PUBLICLY TRADED

    Initiates Process to Terminate Advisory Agreement with Ashford and Its Affiliates in Order to Eliminate Relationship with Ashford and Create Its Own Management Team and New BoardPlans Near-Total Reconstitution of the Board, Including Five New Independent Directors, an Independent Chair, and President and CEO Richard Stockton Continuing His DirectorshipDALLAS, June 12, 2026 /PRNewswire/ -- Braemar Hotels & Resorts Inc. (NYSE:BHR) ("Braemar" or the "Company") today announced a series of actions designed to simplify its corporate structure, reduce costs, enhance governance and position the Company for long-term profitability and value creation. Following the conclusion of a lengthy strategic re

  • Starfighters Space Inc. logo
    Intuitive Machines Inc. logo
    PR··Consumer Discretionary·
    Liftoff: The Day the Orbital Economy Became a Public Market

    Issued on behalf of Starfighters Space, Inc.The sector's defining company is trading on the open market for the first time. A frontier that was private for a generation is now, finally, everyone's to own.Baystreet.ca News CommentaryCAPE CANAVERAL, Fla., June 12, 2026 /CNW/ -- Some market days are remembered less for what a stock did than for what they signified. As reported, today is one of them: SpaceX is set to begin trading publicly on NASDAQ under the ticker SPCX, ending a long era in which the most consequential company in the modern space age remained beyond the reach of public investors. Whatever the first day's price action, the deeper event is structural — the orbital economy now ha

  • Profusa Inc. logo
    PR··Health Care·
    Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform

    BERKELEY, CA, June 12, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (NASDAQ:PFSA), a digital health company pioneering next-generation biosensing technologies, today announces that it has submitted its response package to questions received from its European Notified Body, GMED, following the successful completion of the Stage 1 and Stage 2 quality system and technical documentation assessments conducted by GMED as part of the MDR conformity assessment process for the Lumee® Oxygen Platform. The response package included updates across multiple aspects of the MDR submission, including technical documentation, quality system evidence, clinical evaluation activities, and supporting validation in

  • Momentus Inc. logo
    PR··Industrials·
    Momentus Announces Pricing of a $25 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules with New and Existing Fundamental Institutional Investors

    Momentus Inc. (NASDAQ:MNTS) ("Momentus" or the "Company") a leading U.S. commercial space firm specializing in satellite solutions, in-space transportation, and orbital infrastructure, today announced that it has entered into securities purchase agreements with new and existing long term institutional investors for the purchase and sale of 1,851,852 shares of its common stock in a registered direct offering priced at-the-market under Nasdaq rules (the "Offering"). The gross proceeds from the Offering are expected to be approximately $25 million, before deducting placement agent fees and other estimated Offering expenses. The closing of the Offering is expected to occur on or about June 15

  • Rocket Companies Inc. logo
    PR··Finance·
    SpaceX Employees Could Buy 2 in 5 San Antonio Homes With Their IPO Windfall

    Redfin reports the massive IPO would create enough wealth for SpaceX employees to buy roughly 40% of all the homes in San Antonio, one of the closest major metros to where the company is headquartered. Or they could buy every single home in McAllen, located just 80 miles away from SpaceX headquarters. Alternatively, they could buy 5% of all homes in the Los Angeles metro, where the company was founded.With the wealth created through SpaceX's massive IPO, current and former employees could hypothetically pool their money to buy an estimated 40% of all homes in San Antonio, according to a new report from Redfin, the real estate brokerage powered by Rocket. San Antonio is the closest major U.S.

  • Cel-Sci Corporation logo
    PR··Health Care·
    CEL-SCI and Saudi Amarox to Conduct Signing Ceremony at BIO 2026 for Strategic Agreement to Advance Commercialization and Distribution of Multikine® in Saudi Arabia

    Saudi Arabia Emerges as a Global Biotech Investment Hub Under Vision 2030 Senior Saudi Government, Investment and Healthcare Leaders to Attend the CEL-SCI / Amarox Signing & Opening Ceremonies Strategic Agreement Marks Important Step Toward Commercialization of Multikine® in One of the Middle East's Fastest-Growing Healthcare Markets CEL-SCI Corporation (NYSE:CVM) today announced it will participate in a formal signing ceremony with Saudi Amarox ("Amarox") during the BIO International Convention 2026 in San Diego, California. The ceremony will mark an important milestone in advancing the previously announced strategic agreement between the companies focused on the commercialization an

  • Cogent Biosciences Inc. logo
    PR··Health Care·
    Cogent Biosciences Announces Detailed Data from APEX Pivotal Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis at the 2026 European Hematology Association (EHA) Congress

    -- Bezuclastinib demonstrated rapid and deep clinical benefit in AdvSM patients resulting in an updated objective response rate (CR+CRh+PR+CI) of 65% per mIWG criteria and 81% ORR per PPR criteria – -- Bezuclastinib demonstrated a powerful effect on mast cell burden with 91% of patients achieving ≥50% reduction in variant allele frequency and 89% of patients achieving ≥50% reduction in bone marrow mast cells or clearance of aggregates – -- Bezuclastinib continues to demonstrate a favorable safety and tolerability profile – -- APEX NDA to be submitted in June 2026 – WALTHAM, Mass. and BOULDER, Colo., June 12, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (NASDAQ:COGT), a biotechnolo

  • Independent Bank Corporation logo
    PR··Finance·
    Independent Bank Corporation Announces Regulatory Approvals to Acquire HCB Financial Corp. and Highpoint Community Bank

    GRAND RAPIDS, Mich. and HASTINGS, Mich., June 12, 2026 (GLOBE NEWSWIRE) -- Independent Bank Corporation (NASDAQ:IBCP), the parent company of Independent Bank, with total assets of approximately $5.5 billion, and HCB Financial Corp. ("HCB"), the parent company of Highpoint Community Bank, with total assets of approximately $590 million, previously announced the signing of a definitive merger agreement on March 18, 2026 for IBCP to acquire HCB. The proposed transaction has been approved by both the Federal Reserve Bank of Chicago and the Michigan Department of Insurance and Financial Services. A meeting of the HCB shareholders has been scheduled for June 17, 2026 to consider and vote upon

  • BrightSpring Health Services Inc. logo
    PR··Health Care·
    BrightSpring Health Services, Inc. Welcomes Dr. Nigam H. Shah to Board of Directors

    LOUISVILLE, Ky., June 12, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "the Company") (NASDAQ:BTSG), a leading provider of home- and community-based pharmacy and health services for complex populations, announced that Dr. Nigam H. Shah was appointed as a Class III member of the Board of Directors on June 11, 2026. Dr. Shah will also serve as a member of the Board's Quality and Compliance Committee. Dr. Shah joined Stanford University as an Assistant Professor of Medicine in 2011, was tenured in 2015, and promoted to Professor of Medicine and Biomedical Data Science in 2020. Dr. Shah currently serves as the Chief Data Scientist at Stanford Healthcare and Associa

  • Kalaris Therapeutics Inc. logo
    PR··Health Care·
    Kalaris to Present at Clinical Trials at the Summit 2026

    BERKELEY HEIGHTS, N.J., June 12, 2026 (GLOBE NEWSWIRE) -- Kalaris Therapeutics, Inc. (NASDAQ:KLRS) ("Kalaris"), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases, will present Phase 1a clinical data for its lead asset, TH103, at Clinical Trials at the Summit (CTS) 2026. The presentation will feature single ascending dose results from treatment-naïve patients with Neovascular Age-Related Macular Degeneration (AMD) — one of the leading causes of vision loss worldwide. These data were recently presented at Retina World Congress 2026. Details: Title: First-in-Human Trial of TH103: A Novel Dual-Targeting

  • Rezolve AI PLC logo
    PR··Technology·
    Rezolve Ai Board Moves to Authorize Capital Reduction and Up to $300 Million Share Repurchase Program

    NEW YORK, June 12, 2026 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ:RZLV), ("Rezolve Ai" or the "Company"), a global leader in AI-powered commerce, today announced that its Board of Directors will seek authority at the Company's upcoming annual general meeting to be held on June 30, 2026, to approve a capital reduction and an agreement with BTIG, a global financial services firm, enabling the Company to repurchase up to $300 million of ordinary shares. The proposed program reflects the Board's confidence in Rezolve Ai's long-term prospects and its belief that the Company's current public market valuation does not reflect the strength of the business, the progress achieved since listing, or the

  • Inspire Medical Systems Inc. logo
    PR··Health Care·
    Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight

    MINNEAPOLIS, June 12, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will participate in the Wells Fargo 2026 MedTech Innovation Spotlight on Friday, June 26, 2026. Inspire is scheduled to speak at 10:00 a.m. Eastern Time. The presentation will be accessible via a live webcast here. A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire's Investor website at https://investors